Search - tctmd.com

Displaying 121 - 140 of 710

Sort: Relevancy | Date

News Daily News

Subestudio ADAPT-DES: Los Cambios de la Práctica podrían disminuir aún más los ya bajos índices de trombosis del stent

Yael L. Maxwell

October 09, 2015

News Industry News

Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015

October 07, 2015

News Daily News

在PCI患者中切入部位和坎格雷洛之间没有相互作用

Caitlin E. Cox

October 06, 2015

News Industry News

SurModics Receives FDA IDE Approval for Early Feasibility Study of the SurVeil™ Drug-Coated Balloon

October 06, 2015

News Daily News

No Interplay Between Access Site, Cangrelor Effects in PCI Patients

Caitlin E. Cox

October 06, 2015

News Daily News

No hay interacción entre el punto de acceso y los efectos del Cangrelor en pacientes con PCI

Caitlin E. Cox

October 06, 2015

News Daily News

观察性研究揭示了血管内和手术方案在治疗症状性 PAD 时的差异

L.A. McKeown

October 05, 2015

News Daily News

Un Estudio observacional Arroja Luz sobre las Opciones Endovascular y Quirúrgica para la EAP Sintomática

L.A. McKeown

October 05, 2015

News Daily News

Observational Study Sheds Light on Endovascular vs Surgical Options for Symptomatic PAD

L.A. McKeown

October 05, 2015

Presentation

Lower Extremity Bypass Surgery and Peripheral Endovascular Interventions for Symptomatic PAD

Presenter: Thomas T. Tsai

October 02, 2015

News Daily News

在采用TAVR的早期，在试验中心以外接受治疗的患者的死亡率并非更高

October 01, 2015

News Daily News

In the Early Days of TAVR, No Mortality Penalty for Patients Treated Outside of Trial Centers

October 01, 2015

News Industry News

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

September 30, 2015

News Daily News

Public Reporting of PCI Mortality Tied to Fewer High-Risk Cases But Better Outcomes

September 24, 2015

News Daily News

PCI 死亡率公开与高危病例更少但结局更好相关

September 24, 2015

News Daily News

Registro OLIVE: ‘Razonables’ Resultados del Tratamiento Endovascular para el Manejo de la ICE a los 3 Años

L.A. McKeown

September 23, 2015

News Daily News

OLIVE登记处：3年时的CLI血管内临床治疗结果“合情合理”

L.A. McKeown

September 23, 2015

News Daily News

OLIVE Registry: Endovascular Therapy Outcomes for CLI ‘Reasonable’ at 3 Years

L.A. McKeown

September 23, 2015

Presentation Aortovascular 2015

The Medical Treatment of the Patient with PAD in the 21st Century

Presenter: Michael R. Jaff

September 18, 2015

Presentation Aortovascular 2015

The Antiproliferative Endovascular Era in PAD Treatment: Are we there yet?

Presenter: Danielle R. Bajakian

September 18, 2015

Advertisement

Subestudio ADAPT-DES: Los Cambios de la Práctica podrían disminuir aún más los ya bajos índices de trombosis del stent

Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015

在PCI患者中切入部位和坎格雷洛之间没有相互作用

SurModics Receives FDA IDE Approval for Early Feasibility Study of the SurVeil™ Drug-Coated Balloon

No Interplay Between Access Site, Cangrelor Effects in PCI Patients

No hay interacción entre el punto de acceso y los efectos del Cangrelor en pacientes con PCI

观察性研究揭示了血管内和手术方案在治疗症状性 PAD 时的差异

Un Estudio observacional Arroja Luz sobre las Opciones Endovascular y Quirúrgica para la EAP Sintomática

Observational Study Sheds Light on Endovascular vs Surgical Options for Symptomatic PAD

Lower Extremity Bypass Surgery and Peripheral Endovascular Interventions for Symptomatic PAD

在采用TAVR的早期，在试验中心以外接受治疗的患者的死亡率并非更高

In the Early Days of TAVR, No Mortality Penalty for Patients Treated Outside of Trial Centers

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

Public Reporting of PCI Mortality Tied to Fewer High-Risk Cases But Better Outcomes

PCI 死亡率公开与高危病例更少但结局更好相关

Registro OLIVE: ‘Razonables’ Resultados del Tratamiento Endovascular para el Manejo de la ICE a los 3 Años

OLIVE登记处：3年时的CLI血管内临床治疗结果“合情合理”

OLIVE Registry: Endovascular Therapy Outcomes for CLI ‘Reasonable’ at 3 Years

The Medical Treatment of the Patient with PAD in the 21st Century

The Antiproliferative Endovascular Era in PAD Treatment: Are we there yet?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content